GOEL DAVID E. 4
4 · Adaptive Biotechnologies Corp · Filed Jul 2, 2019
Insider Transaction Report
Form 4
GOEL DAVID E.
Director10% OwnerOther
Transactions
- Conversion
Common Stock
2019-07-01+200,000→ 200,000 total(indirect: See footnotes) - Conversion
Common Stock
2019-07-01+5,893,716→ 6,093,716 total(indirect: See footnotes) - Conversion
Common Stock
2019-07-01+84,359→ 17,332,191 total(indirect: See footnotes) - Conversion
Series E-1 Convertible Preferred Stock
2019-07-01−5,893,716→ 0 total(indirect: See footnotes)Exercise: $6.04→ Common Stock (5,893,716 underlying) - Conversion
Common Stock
2019-07-01+11,154,116→ 17,247,832 total(indirect: See footnotes) - Conversion
Series A Convertible Preferred Stock
2019-07-01−200,000→ 0 total(indirect: See footnotes)Exercise: $1.00→ Common Stock (200,000 underlying) - Conversion
Series F Convertible Preferred Stock
2019-07-01−11,154,116→ 0 total(indirect: See footnotes)Exercise: $8.97→ Common Stock (11,154,116 underlying) - Conversion
Series F-1 Convertible Preferred Stock
2019-07-01−84,359→ 0 total(indirect: See footnotes)Exercise: $10.67→ Common Stock (84,359 underlying)
Footnotes (3)
- [F1]All of the shares of convertible preferred stock automatically converted into shares of the Issuer's common stock upon the closing of the Issuer's initial public offering. The convertible preferred stock had no expiration date.
- [F2]The securities reported herein are held by Matrix Capital Management Master Fund, LP (the "Matrix Fund"). Matrix Capital Management Company, LP (the "Investment Manager"), a Delaware limited partnership, is the investment advisor to the Matrix Fund. Mr. David E. Goel ("Mr. Goel", and together with the Investment Manager, the "Reporting Persons"), serves as the Managing General Partner of the Investment Manager.
- [F3]The filing of this statement shall not be deemed an admission that either of the Reporting Persons is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. Each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of its or his pecuniary interest therein.